![Jeremy Cress](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeremy Cress
Directeur Technique/Scientifique/R&D chez Castle Creek Biosciences, Inc.
Postes actifs de Jeremy Cress
Sociétés | Poste | Début | Fin |
---|---|---|---|
Castle Creek Biosciences, Inc.
![]() Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Corporate Officer/Principal | - | - |
Directeur Technique/Scientifique/R&D | - | - | |
Directeur des opérations | - | - |
Historique de carrière de Jeremy Cress
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Castle Creek Biosciences, Inc.
![]() Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
- Bourse
- Insiders
- Jeremy Cress
- Expérience